Your browser doesn't support javascript.
loading
Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
Liu, Yunshuang; Li, Hongzhi; Liu, Jieting; Han, Pengfei; Li, Xuefeng; Bai, He; Zhang, Chunlei; Sun, Xuelian; Teng, Yanjie; Zhang, Yufei; Yuan, Xiaohuan; Chu, Yanhui; Zhao, Binghai.
Afiliación
  • Liu Y; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Li H; Clinical Laboratory of Hong Qi Hospital, Mudanjiang Medical University, Heilongjiang, People's Republic of China.
  • Liu J; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Han P; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Li X; Clinical Laboratory of Hong Qi Hospital, Mudanjiang Medical University, Heilongjiang, People's Republic of China.
  • Bai H; Clinical Laboratory of Hong Qi Hospital, Mudanjiang Medical University, Heilongjiang, People's Republic of China.
  • Zhang C; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Sun X; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Teng Y; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Zhang Y; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Yuan X; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Chu Y; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Zhao B; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and yanhui_chu@163.com zhaobinghai01@163.com.
J Am Soc Nephrol ; 28(12): 3627-3638, 2017 Dec.
Article en En | MEDLINE | ID: mdl-28923913

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación de la Expresión Génica / MicroARNs / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas Límite: Animals / Humans / Male Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación de la Expresión Génica / MicroARNs / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas Límite: Animals / Humans / Male Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos